04:30 PM EDT, 06/28/2024 (MT Newswires) -- John M. Evans, Director, CEO, on June 27, 2024, sold 60,000 shares in Beam Therapeutics ( BEAM ) for $1,470,156. Following the Form 4 filing with the SEC, Evans has control over a total of 1,101,343 shares of the company, with 998,343 shares held directly and 103,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1745999/000095017024079065/xslF345X03/ownership.xml